BioWorld MedTech

Dec. 31, 2014

CytoSorbents seeks IDE for intra-operative use of CytoSorb treatment

A device designed to be installed into a heart-lung machine and used intra-operatively during complex cardiac surgery in an effort to reduce post-operative complications may soon be making its way through the U.S. regulatory process. Read More

Six leading research centers launch Cancer Core Europe

Alpinion Medical Systems rolls out South Korea's first HIFU

Kalorama identifies top trends that impacted med-tech in 2014

Abbott sheds light on early results for tender offer

Heart Sync electrode latest in slew of recalls related to Philips AEDs

Briefly Noted

Modernizing Medicine completes acquisition of Aesyntix Health

Keeping you up to date on recent events with Oncology

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Sangamo presents primate data for prion suppressor ST-506

BioWorld Science

Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...

TREM2 agonists detailed in Pfizer patent

BioWorld Science

Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...